SCHEMBL1013565

SCHEMBL1013565

NS(=O)(=O)c1ccccc1OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.56
CA2 P00918 3/20 0.56
CA9 Q16790 3/20 0.56
CA12 O43570 2/20 0.56
CA4 P22748 1/20 0.56
CA5A P35218 1/20 0.56
CA7 P43166 1/20 0.56
CA5B Q9Y2D0 1/20 0.56
PTGES2 Q9H7Z7 1/20 0.52
MAPT P10636 1/20 0.50
MAPK1 P28482 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
LTA4H P09960 1/20 0.49
MAPK14 Q16539 1/20 0.49
P2RX4 Q99571 1/20 0.48
ALPG P10696 1/20 0.47
PTK2B Q14289 1/20 0.47
HTR1A P08908 1/20 0.47
DRD2 P14416 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32664684 0.87 ABCB1 (0.50) CA1CA2CA9CA12CA4
SCHEMBL10619752 0.87 ABCB1 (0.50) CA1CA2CA9CA12CA4
SCHEMBL7108877 0.85 MAPT (0.53) CA1CA2CA9CA12CA4
SCHEMBL29965415 0.84 NPC1 (0.54) CA1CA2CA9CA12CA4
SCHEMBL10622816 0.83 HTR1A (0.55) CA1CA2CA9CA12MAPK1
SCHEMBL32664452 0.83 HTR1A (0.55) CA1CA2CA9CA12MAPK1
SCHEMBL1028419 0.82 ALPG (0.51) MAPTMAPK1TDP1L3MBTL1LTA4H
SCHEMBL1500952 0.82 MAPT (0.50) CA1CA2CA9CA12CA4
SCHEMBL4164605 0.82 MAPT (0.55) MAPTMAPK1TDP1L3MBTL1LTA4H
SCHEMBL4649389 0.81 CA1 (0.48) CA1CA2CA9CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0044807-B1 N-PHENYLSULFONYL-N'-PYRIMIDINYL- AND -TRIAZINYL UREAS CIBA-GEIGY AG (CH) 1985-11-21 EP claimed
EP-3122353-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS Vanderbilt University (US) 2017-02-01 EP disclosed
WO-2015148854-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY (US) 2015-10-01 WO disclosed
US-8048862-B2 Macrocyclic inhibitors of hepatitis C virus replication INTERMUNE, INC. (US) 2011-11-01 US disclosed
US-20110059047-A1 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2011-03-10 US disclosed
EP-2272858-A2 HCV inhibitors comprising beta amino acids and their uses Novartis AG (CH) 2011-01-12 EP disclosed
US-20090269305-A1 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-10-29 US disclosed
US-4661146-A PLANT GROWTH REGULATORS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-04-28 US disclosed
US-4565887-A PLANT GROWTH AGENTS, HERBICIDES CIBA-GEIGY CORP. (US) 1986-01-21 US disclosed
US-4523944-A HERBICIDES CIBA-GEIGY CORPORATION (US) 1985-06-18 US disclosed
US-4500344-A Herbicidal ortho-(alkoxy)-benzenesulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-02-19 US disclosed
US-4487951-A INTERMEDIATES FOR PLANT GROWTH REGULATORS AND HERBICIDES CIBA-GEIGY CORPORATION (US) 1984-12-11 US disclosed
US-4443243-A HERBICIDES CIBA-GEIGY CORPORATION (US) 1984-04-17 US disclosed
US-4425153-A Herbicidal sulfonamides E. I. DU PONT DE NEMOURS & CO. (US) 1984-01-10 US disclosed
EP-0094790-A2 Herbicidal O-alkoxybenzenesulfonamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1983-11-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090269305-A1 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION EIF2AK2, HAVCR2, ZC3HAV1 CA1 4730/4885CA2 4581/4885CA9 4082/4885
US-20110059047-A1 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION EIF2AK2, HAVCR2, ZC3HAV1 CA1 4730/4885CA2 4581/4885CA9 4082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.